xeomin 200 enot prašek za raztopino za injiciranje
merz pharmaceuticals gmbh - botulinski toksin tipa ia - prašek za raztopino za injiciranje - botulinski toksin tipa ia 200 e. / 1 viala - botulinski toksin
xeomin 200 enot prašek za raztopino za injiciranje
merz pharmaceuticals gmbh - botulinski toksin tipa ia - prašek za raztopino za injiciranje - botulinski toksin tipa ia 200 e. / 1 viala - botulinski toksin
takhzyro
takeda pharmaceuticals international ag ireland branch - lanadelumab - angioedem, dedno - other hematological agents - takhzyro is indicated for routine prevention of recurrent attacks of hereditary angioedema (hae) in patients aged 2 years and older.
etonogestrel/etinilestradiol mithra pharmaceuticals 0,120 mg/0,015 mg na 24 ur vaginalni dostavni sistem
etinilestradiol; etinilestradiol; etonogestrel - vaginalni dostavni sistem - etinilestradiol 2,7 mg / 1 sistem etinilestradiol2,7 mg / 1 sistem etonogestrel11,7 mg / 1 sistem; etinilestradiol 2,7 mg / 1 sistem etonogestrel11,7 mg / 1 sistem; etonogestrel 11,7 mg / 1 sistem - vaginalni obroček s progestogenom in estrogenom
firazyr
takeda pharmaceuticals international ag - ikatibant - angioedem, dedno - srčna terapija - zdravilo firazyr je indicirano za simptomatsko zdravljenje akutnih napadov dednega angioedema (hae) pri odraslih (s pomanjkanjem inhibitorja c1-esteraze).
imoxat
chanelle pharmaceuticals manufacturing ltd - imidacloprid, moxidectin - antiparasitic products, insecticides and repellents, macrocyclic lactones, milbemycins - cats; dogs; ferrets - for cats suffering from, or at risk from, mixed parasitic infections:• the treatment and prevention of flea infestation (ctenocephalides felis),• the treatment of ear mite infestation (otodectes cynotis),• the treatment of notoedric mange (notoedres cati),• the treatment of the lungworm eucoleus aerophilus (syn. capillaria aerophila) (adults),• the prevention of lungworm disease (l3/l4 larvae of aelurostrongylus abstrusus),• the treatment of the lungworm aelurostrongylus abstrusus (adults),• the treatment of the eye worm thelazia callipaeda (adults),• the prevention of heartworm disease (l3 and l4 larvae of dirofilaria immitis),• the treatment of infections with gastrointestinal nematodes (l4 larvae, immature adults and adults of toxocara cati and ancylostoma tubaeforme). zdravilo za uporabo v veterinarski medicini se lahko uporablja kot del strategije zdravljenja alergijskega dermatitisa bolh (fad). for ferrets suffering from, or at risk from, mixed parasitic infections:• the treatment and prevention of flea infestation (ctenocephalides felis),• the prevention of heartworm disease (l3 and l4 larvae of dirofilaria immitis). for dogs suffering from, or at risk from, mixed parasitic infections:• the treatment and prevention of flea infestation (ctenocephalides felis),• the treatment of biting lice (trichodectes canis),• the treatment of ear mite infestation (otodectes cynotis), sarcoptic mange (caused by sarcoptes scabiei var. canis), demodicosis (caused by demodex canis),• the prevention of heartworm disease (l3 and l4 larvae of dirofilaria immitis),• the treatment of circulating microfilariae (dirofilaria immitis),• the treatment of cutaneous dirofilariosis (adult stages of dirofilaria repens)• the prevention of cutaneous dirofilariosis (l3 larvae of dirofilaria repens),• the reduction of circulating microfilariae (dirofilaria repens),• the prevention of angiostrongylosis (l4 larvae and immature adults of angiostrongylus vasorum),• the treatment of angiostrongylus vasorum and crenosoma vulpis,• the prevention of spirocercosis (spirocerca lupi),• the treatment of eucoleus (syn. capillaria) boehmi (adults),• the treatment of the eye worm thelazia callipaeda (adults),• the treatment of infections with gastrointestinal nematodes (l4 larvae, immature adults and adults of toxocara canis, ancylostoma caninum and uncinaria stenocephala, adults of toxascaris leonina and trichuris vulpis). zdravilo za uporabo v veterinarski medicini se lahko uporablja kot del strategije zdravljenja alergijskega dermatitisa bolh (fad).
clopidogrel acino
acino ag - klopidogrel - peripheral vascular diseases; acute coronary syndrome; myocardial infarction; stroke - antitrombotična sredstva - clopidogrel is indicated in adults for the prevention of atherothrombotic events in: , , , patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease, non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa), st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy, patients suffering from acute coronary syndrome. , ,.
revestive
takeda pharmaceuticals international ag ireland branch - teduglutid - malabsorpcijski sindromi - drugi zdravljene bolezni prebavil in presnove izdelki, - revesiven je indiciran za zdravljenje bolnikov, starih 1 leto in več, s kratkim bowelovim sindromom (sbs). bolniki morajo biti po obdobju kirurške prilagoditve črevesja stabilni. revestive je indiciran za zdravljenje bolnikov, starih 1 leto in več s kratkimi Črevesja. bolniki morajo biti po obdobju kirurške prilagoditve črevesja stabilni.
sugammadex amomed
aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuskularna blokada - vsi drugi terapevtski izdelki - zavrnitev nevromuskularne blokade, ki jo inducira rocuronium ali vecuronium. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
aripiprazole mylan pharma (previously aripiprazole pharmathen)
mylan pharmaceuticals limited - aripiprazol - schizophrenia; bipolar disorder - psiholeptiki - aripiprazol mylan pharma je indiciran za zdravljenje shizofrenije pri odraslih in pri mladostnikih, starih 15 let ali več. aripiprazole mylan pharma je primerna za zdravljenje zmerno do hudo manične epizode v bipolarne motnje i bolezni in za preprečevanje novo manično epizodo pri odraslih, ki so imeli pretežno manične epizode in katerih manične epizode se odzvali na zdravljenje aripiprazole. aripiprazole mylan pharma je primerna za zdravljenje do 12 tednov, z zmerno do hudo manične epizode v bipolarne motnje i motnje pri mladostnikih, ki so stari 13 let in starejši.